Jupiter Neurosciences Appoints NBA Legend Chris Webber as Nugevia Brand Ambassador

Jupiter Neurosciences has partnered with NBA legend Chris Webber as its second brand ambassador for Nugevia, a new longevity supplement line. The partnership expands momentum for the launch of the new supplement line, which is powered by clinical science and performance-driven innovation. Webber brings his championship mindset and commitment to peak performance to the Nugevia mission, supporting the company's goal of helping people look, feel, and perform their best at every stage of life.

Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company, has announced a strategic partnership with NBA legend Chris Webber as the second brand ambassador for its Nugevia™ longevity supplement line. The collaboration underscores Jupiter's dual-path strategy, which combines consumer health products with clinical-stage CNS therapies to target the rapidly growing $8 trillion longevity market by 2030 [1].

Webber, a five-time NBA All-Star and Hall of Fame inductee, brings his championship mindset and commitment to peak performance to the Nugevia mission. Over his career, Webber was named NBA Rookie of the Year, earned five All-NBA selections, and left an indelible mark on the game with his skill, vision, and leadership. "Chris embodies the principles at the core of Nugevia™: longevity, resilience, and elite performance supported by real science," said Christer Rosén, Chairman and CEO of Jupiter Neurosciences. "His dedication to preparation and his commitment to excellence both on and off the court make him an ideal advocate for our mission to help people look, feel, and perform their best at every stage of life."

The Nugevia™ supplement line features three formulations—GLO, MND, and PWR—designed to support cellular resilience through intelligent stacking of synergistic ingredients, all enhanced for optimal absorption. The line is built on JOTROL™, Jupiter's patented resveratrol-based micellar delivery platform, which has demonstrated significantly enhanced bioavailability and underpins the Company's clinical-stage CNS therapies [2].

The partnership with Webber expands momentum for the launch of the new supplement line, which is scheduled to be commercially available through direct-to-consumer e-commerce platforms starting Fall 2025. The consumer initiative supports Jupiter's goal of generating high-margin revenue and collecting valuable data to inform future cognitive health programs.

References:
[1] https://www.marketscreener.com/news/jupiter-neurosciences-introduces-nugevia-mnd-a-cognitive-health-supplement-leveraging-clinically-va-ce7c51dadb8df024
[2] https://www.stocktitan.net/news/JUNS/jupiter-neurosciences-names-nba-legend-chris-webber-as-second-jm6ol5ftmlvr.html